002022 科华生物
已收盘 04-24 15:00:00
资讯
新帖
简况
科华生物:集采及区域检测中心建设项目
证券之星 · 04-21
科华生物:集采及区域检测中心建设项目
科华生物:计提信用减值损失、资产减值损失和折旧与摊销虽然会减少净利润,但不会有现金流出
证券之星 · 04-21
科华生物:计提信用减值损失、资产减值损失和折旧与摊销虽然会减少净利润,但不会有现金流出
科华生物(002022)披露2025年年度审计报告,4月20日股价上涨1.39%
证券之星 · 04-20
科华生物(002022)披露2025年年度审计报告,4月20日股价上涨1.39%
科华生物(002022)披露2025年年度报告,4月17日股价下跌2.05%
中金财经 · 04-17
科华生物(002022)披露2025年年度报告,4月17日股价下跌2.05%
科华生物(002022)3月31日股东户数4.83万户,较上期增加7.12%
证券之星 · 04-17
科华生物(002022)3月31日股东户数4.83万户,较上期增加7.12%
科华生物最新公告:2025年净亏损7.32亿元
证券之星 · 04-16
科华生物最新公告:2025年净亏损7.32亿元
科华生物最新公告:两款产品获得医疗器械注册证
证券之星 · 04-10
科华生物最新公告:两款产品获得医疗器械注册证
股市必读:科华生物(002022)4月3日董秘有最新回复
证券之星 · 04-07
股市必读:科华生物(002022)4月3日董秘有最新回复
科华生物(002022)披露2026年第一季度可转债转股情况,4月2日股价下跌0.33%
证券之星 · 04-02
科华生物(002022)披露2026年第一季度可转债转股情况,4月2日股价下跌0.33%
科华生物:公司2026年第一季度报告将于2026年4月28日披露
证券之星 · 04-02
科华生物:公司2026年第一季度报告将于2026年4月28日披露
科华生物(002022)披露全资子公司产品获医疗器械注册证,3月30日股价上涨1.19%
证券之星 · 03-30
科华生物(002022)披露全资子公司产品获医疗器械注册证,3月30日股价上涨1.19%
科华生物:持续高质量发展是市值管理的基础
证券之星 · 03-25
科华生物:持续高质量发展是市值管理的基础
科华生物(002022)披露控股子公司实时荧光定量PCR仪获医疗器械注册证,3月23日股价下跌5.74%
证券之星 · 03-23
科华生物(002022)披露控股子公司实时荧光定量PCR仪获医疗器械注册证,3月23日股价下跌5.74%
科华生物(002022.SZ)子公司取得一项医疗器械注册证
智通财经 · 03-23
科华生物(002022.SZ)子公司取得一项医疗器械注册证
科华生物:公司在自产产品聚焦生化诊断、免疫诊断、分子诊断、即时诊断(POCT)和质谱五大板块
证券之星 · 03-20
科华生物:公司在自产产品聚焦生化诊断、免疫诊断、分子诊断、即时诊断(POCT)和质谱五大板块
科华生物:拟申请10亿元融资及8亿元并购贷款
证券之星 · 03-12
科华生物:拟申请10亿元融资及8亿元并购贷款
科华生物:持续高质量发展是市值管理的基础
证券之星 · 03-11
科华生物:持续高质量发展是市值管理的基础
科华生物(002022)披露2026年度向金融机构融资和为子公司提供担保的公告,3月9日股价下跌0.5%
证券之星 · 03-09
科华生物(002022)披露2026年度向金融机构融资和为子公司提供担保的公告,3月9日股价下跌0.5%
股市必读:科华生物(002022)3月6日董秘有最新回复
证券之星 · 03-09
股市必读:科华生物(002022)3月6日董秘有最新回复
股市必读:科华生物(002022)2月26日董秘有最新回复
证券之星 · 02-27
股市必读:科华生物(002022)2月26日董秘有最新回复
加载更多
公司概况
公司名称:
上海科华生物工程股份有限公司
所属行业:
医药制造业
上市日期:
2004-07-21
主营业务:
上海科华生物工程股份有限公司的主营业务是体外诊断试剂、仪器的研发、生产和销售。公司的主要产品是体外诊断试剂、仪器。公司及子公司曾获得“国家科技进步二等奖”“国家高新技术企业”“国家知识产权示范企业”“国家发改委生物医学工程高技术产业化示范企业”“中国中小企业创新100强”“上海市著名商标证书”“上海名牌”“上海市科学技术奖”“上海市创新型企业”“陕西省和西安市创新型企业”“陕西省院士工作站”等荣誉,并多次入选上海百强企业多项榜单。
发行价格:
11.12
{"stockData":{"symbol":"002022","market":"SZ","secType":"STK","nameCN":"科华生物","latestPrice":5.77,"timestamp":1777014180000,"preClose":5.69,"halted":0,"volume":7101382,"delay":0,"changeRate":0.0141,"floatShares":513999999,"shares":513999999,"eps":-1.6014,"marketStatus":"已收盘","change":0.08,"latestTime":"04-24 15:00:00","open":5.69,"high":5.79,"low":5.64,"amount":40606200,"amplitude":0.0264,"askPrice":5.78,"askSize":1006,"bidPrice":5.77,"bidSize":149,"shortable":0,"etf":0,"ttmEps":-1.6014,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777253400000},"marketStatusCode":5,"adr":0,"adjPreClose":5.69,"symbolType":"stock","openAndCloseTimeList":[[1776994200000,1777001400000],[1777006800000,1777014000000]],"highLimit":6.26,"lowLimit":5.12,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":514350669,"isCdr":false,"pbRate":1.13,"roa":"--","roe":"--","epsLYR":-1.4235,"committee":-0.725197,"marketValue":2968000000,"turnoverRate":0.0138,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2026-04-27。","floatMarketCap":2967000000},"requestUrl":"/m/hq/s/002022","defaultTab":"news","newsList":[{"id":"2629709555","title":"科华生物:集采及区域检测中心建设项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2629709555","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629709555?lang=zh_cn&edition=full","pubTime":"2026-04-21 11:33","pubTimestamp":1776742386,"startTime":"0","endTime":"0","summary":"证券之星消息,科华生物04月20日在投资者关系平台上答复投资者关心的问题。公司公开发行可转换公司债券的募投项目“集采及区域检测中心建设项目”“化学发光生产线建设项目(调整)”在实施过程中,受市场环境变化、行业发展变化等多方面因素的影响,建设进度较预计有所延缓,无法在计划时间内达到预定可使用状态。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100024514.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","002022","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629709598","title":"科华生物:计提信用减值损失、资产减值损失和折旧与摊销虽然会减少净利润,但不会有现金流出","url":"https://stock-news.laohu8.com/highlight/detail?id=2629709598","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629709598?lang=zh_cn&edition=full","pubTime":"2026-04-21 11:33","pubTimestamp":1776742385,"startTime":"0","endTime":"0","summary":"2、经营活动产生的现金净流量与本年度净利润的差异原因主要为:计提信用减值损失、资产减值损失和折旧与摊销虽然会减少净利润,但不会有现金流出;递延所得税资产冲回会减少净利润,但不会有现金流出;经营性应收款项的减少,表明收到以前年度货款,影响现金流量,但不影响净利润。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100024510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159399","002022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628746045","title":"科华生物(002022)披露2025年年度审计报告,4月20日股价上涨1.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628746045","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628746045?lang=zh_cn&edition=full","pubTime":"2026-04-20 17:42","pubTimestamp":1776678149,"startTime":"0","endTime":"0","summary":"截至2026年4月20日收盘,科华生物报收于5.82元,较前一交易日上涨1.39%,最新总市值为29.94亿元。近日,科华生物发布2025年年度审计报告。公告显示,容诚会计师事务所对上海科华生物工程股份有限公司2025年度财务报表进行了审计,出具了标准无保留意见的审计报告。审计报告显示,科华生物2025年12月31日的合并及母公司财务状况,以及2025年度的经营成果和现金流量在所有重大方面按照企业会计准则的规定编制,公允反映了公司的财务状况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000024854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002022","BK0239","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628277632","title":"科华生物(002022)披露2025年年度报告,4月17日股价下跌2.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628277632","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628277632?lang=zh_cn&edition=full","pubTime":"2026-04-17 18:02","pubTimestamp":1776420136,"startTime":"0","endTime":"0","summary":"h2,h3,h4{padding: 10px 0;font-size: 16px;line-height: 30px;color:#262626;font-weight: 600;}h2{border-bottom: 1px solid #d8dee4; padding-bottom: 0.3em}.article_content ul{padding-left:22px;}截至2026年4月17日收盘,科华生物报收于5.74元,较前一交易日下跌2.05%,最新总市值为29.52亿元。该股当日开盘5.84元,最高5.85元,最低5.63元,成交额达6652.52万元,换手率为2.26%。公司于2026年4月17日披露《2025年年度报告》。报告显示,科华生物2025年末总资产为4,641,435,221.85元,归属于上市公司股东的净资产为2,637,914,841.01元,较上年末分别减少11.36%和21.25%。经营活动产生的现金流量净额为22,438,665.38元,同比增长144.77%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260417/32152056.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0028","BK0046","BK0188","002022","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628304274","title":"科华生物(002022)3月31日股东户数4.83万户,较上期增加7.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628304274","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628304274?lang=zh_cn&edition=full","pubTime":"2026-04-17 17:12","pubTimestamp":1776417170,"startTime":"0","endTime":"0","summary":"证券之星消息,近日科华生物披露,截至2026年3月31日公司股东户数为4.83万户,较12月31日增加3214.0户,增幅为7.12%。在医疗器械行业个股中,科华生物股东户数高于行业平均水平,截至3月31日,医疗器械行业平均股东户数为2.2万户。从股价来看,2025年12月31日至2026年3月31日,科华生物区间跌幅为1.01%,在此期间股东户数增加3214.0户,增幅为7.12%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700032330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002022","BK0239","BK0188","BK0046","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627218749","title":"科华生物最新公告:2025年净亏损7.32亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627218749","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627218749?lang=zh_cn&edition=full","pubTime":"2026-04-16 20:30","pubTimestamp":1776342604,"startTime":"0","endTime":"0","summary":"科华生物(002022.SZ)公告称,公司发布2025年年度报告摘要,实现营业收入16.42亿元,同比下降6.63%;归属于上市公司股东的净利润为-7.32亿元。公司计划不派发现金红利,不送红股,不以公积金转增股本。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600040193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0046","002022","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626556196","title":"科华生物最新公告:两款产品获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2626556196","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626556196?lang=zh_cn&edition=full","pubTime":"2026-04-10 17:50","pubTimestamp":1775814655,"startTime":"0","endTime":"0","summary":"科华生物(002022.SZ)公告称,公司及控股子公司苏州天隆近日分别收到国家药监局颁发的医疗器械注册证。其中,苏州天隆的“EB病毒核酸测定试剂盒(PCR-荧光探针法)”获证,用于体外定量检测人全血或血浆中的EB病毒DNA核酸;公司的“解脲脲原体核酸检测试剂盒(PCR-荧光法)”获证,用于体外定性检测男性尿道拭子、女性宫颈拭子样本中的解脲脲原体核酸。上述注册证有效期均为5年。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041000031074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK1574","09997","09996","002022","BK0046","BK0188","BK0239","BK0028","BK1100","BK1583","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625601636","title":"股市必读:科华生物(002022)4月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2625601636","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625601636?lang=zh_cn&edition=full","pubTime":"2026-04-07 04:19","pubTimestamp":1775506750,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘,科华生物报收于5.81元,下跌2.68%,换手率1.48%,成交量7.6万手,成交额4434.07万元。董秘最新回复投资者: 请问珠海保联投资控股有限公司近三年有没有减持计划?除此之外,近三年珠海保联持股未发生变化。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700002561.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","002022","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624006605","title":"科华生物(002022)披露2026年第一季度可转债转股情况,4月2日股价下跌0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624006605","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624006605?lang=zh_cn&edition=full","pubTime":"2026-04-02 22:51","pubTimestamp":1775141470,"startTime":"0","endTime":"0","summary":"截至2026年4月2日收盘,科华生物报收于5.97元,较前一交易日下跌0.33%,最新总市值为30.71亿元。该股当日开盘6.01元,最高6.05元,最低5.93元,成交额达4259.92万元,换手率为1.38%。公司于近日披露《关于2026年第一季度可转债转股情况的公告》。公告显示,2026年第一季度,“科华转债”因转股减少23,000元,对应转股数量为1,111股。截至2026年3月31日,公司剩余可转债余额为224,533,900元。公告还披露了公司股份变动情况,总股本由514,349,558股增至514,350,669股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200042884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002022","BK0239","BK0046","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624575373","title":"科华生物:公司2026年第一季度报告将于2026年4月28日披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2624575373","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624575373?lang=zh_cn&edition=full","pubTime":"2026-04-02 15:01","pubTimestamp":1775113277,"startTime":"0","endTime":"0","summary":"证券之星消息,科华生物(002022)04月01日在投资者关系平台上答复投资者关心的问题。投资者提问:贵公司26年一季报什么时候公布?亏多少,有没有预告!科华生物回复:尊敬的投资者,您好!公司2026年第一季度报告将于2026年4月28日披露,详细内容请以公司后续在指定信息披露媒体《证券时报》《中国证券报》《上海证券报》和巨潮资讯网(http://www.cninfo.com.cn)上披露的公告为准。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200019116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002022","BK0188","BK0239","BK0046","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623647315","title":"科华生物(002022)披露全资子公司产品获医疗器械注册证,3月30日股价上涨1.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623647315","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623647315?lang=zh_cn&edition=full","pubTime":"2026-03-30 17:52","pubTimestamp":1774864344,"startTime":"0","endTime":"0","summary":"截至2026年3月30日收盘,科华生物报收于5.96元,较前一交易日上涨1.19%,最新总市值为30.66亿元。近日,上海科华生物工程股份有限公司全资子公司科华(西安)生物工程有限公司收到陕西省药品监督管理局颁发的医疗器械注册证,产品为促甲状腺激素测定试剂盒,注册证编号陕械注准20262400031,有效期至2031年03月25日。该试剂盒用于体外定量测定人血清样本中的促甲状腺激素,临床上用于辅助评价下丘脑-垂体-甲状腺功能。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000024923.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","BK1574","BK0046","BK0028","BK1100","BK0188","BK1583","09996","BK0239","BK1222","002022","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622046308","title":"科华生物:持续高质量发展是市值管理的基础","url":"https://stock-news.laohu8.com/highlight/detail?id=2622046308","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622046308?lang=zh_cn&edition=full","pubTime":"2026-03-25 11:30","pubTimestamp":1774409451,"startTime":"0","endTime":"0","summary":"证券之星消息,科华生物(002022)03月24日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司股价比ST的时候夭折再夭折实控人不增持股份怎么提升公司市值管理增强投资者信心科华生物回复:尊敬的投资者,您好!持续高质量发展是市值管理的基础,公司将持续聚焦主营业务,采取多举措努力提升经营效率并积极发展业务,不断提升自身的综合实力,努力提升公司内在价值。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500019212.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","BK0188","002022","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621707854","title":"科华生物(002022)披露控股子公司实时荧光定量PCR仪获医疗器械注册证,3月23日股价下跌5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621707854","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621707854?lang=zh_cn&edition=full","pubTime":"2026-03-23 22:45","pubTimestamp":1774277119,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘,科华生物报收于5.42元,较前一交易日下跌5.74%,最新总市值为27.88亿元。该股当日开盘5.65元,最高5.71元,最低5.37元,成交额达5982.56万元,换手率为2.09%。近日,上海科华生物工程股份有限公司控股子公司西安天隆科技有限公司收到国家药品监督管理局颁发的医疗器械注册证,产品名称为实时荧光定量PCR仪,注册证编号国械注准20263220324,有效期至2031年2月11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300040127.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","09997","BK1574","BK0046","BK1583","002022","159883","BK1100","09996","BK0239","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621779991","title":"科华生物(002022.SZ)子公司取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2621779991","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621779991?lang=zh_cn&edition=full","pubTime":"2026-03-23 17:08","pubTimestamp":1774256908,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科华生物(002022.SZ)公告,公司控股子公司西安天隆科技有限公司收到国家药品监督管理局颁发的医疗器械注册证,产品名称为:实时荧光定量PCR仪。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417386.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002022","BK1574","BK1222","BK1583","BK0046","09997","BK0028","BK0239","BK1100","BK0188","159883","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620736272","title":"科华生物:公司在自产产品聚焦生化诊断、免疫诊断、分子诊断、即时诊断(POCT)和质谱五大板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2620736272","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620736272?lang=zh_cn&edition=full","pubTime":"2026-03-20 20:51","pubTimestamp":1774011106,"startTime":"0","endTime":"0","summary":"证券之星消息,科华生物(002022)03月19日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,贵公司做生物检测,智能医疗这块,请问公司有在AI智能领域精准检测有布局吗?科华生物回复:尊敬的投资者,您好!公司在自产产品聚焦生化诊断、免疫诊断、分子诊断、即时诊断(POCT)和质谱五大板块,拥有丰富的产品组合,支持多方法学多指标联合检测,赋能精准医疗。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000040357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","BK0239","BK0188","002022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618132226","title":"科华生物:拟申请10亿元融资及8亿元并购贷款","url":"https://stock-news.laohu8.com/highlight/detail?id=2618132226","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618132226?lang=zh_cn&edition=full","pubTime":"2026-03-12 20:51","pubTimestamp":1773319896,"startTime":"0","endTime":"0","summary":"投资者提问:请问贵司贷款十亿两亿给三个亏损公司填补亏损还有八亿准备干嘛科华生物回复:为满足公司及合并报表范围内的子公司生产经营和业务发展需要,公司及子公司拟向金融机构申请不超过人民币100,000万元(含本数)的融资额度及人民币80,000万元(含本数)的并购和项目贷款融资额度,并为资产负债率70%以下的子公司提供担保总额不超过人民币20,000万元(含本数)的连带责任担保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200036759.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002022","BK0239","BK0046","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618917302","title":"科华生物:持续高质量发展是市值管理的基础","url":"https://stock-news.laohu8.com/highlight/detail?id=2618917302","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618917302?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:48","pubTimestamp":1773218889,"startTime":"0","endTime":"0","summary":"证券之星消息,科华生物(002022)03月11日在投资者关系平台上答复投资者关心的问题。投资者提问:请问董秘公司怎么个重视市值管理法科华生物回复:对于公司而言,持续高质量发展是市值管理的基础,公司将持续聚焦主营业务,采取多举措努力提升经营效率并积极发展业务,不断提升自身的综合实力,努力提升公司内在价值。公司会认真落实估值提升计划,严格按照相关规定履行信息披露义务。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100027277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0046","002022","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618627594","title":"科华生物(002022)披露2026年度向金融机构融资和为子公司提供担保的公告,3月9日股价下跌0.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618627594","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618627594?lang=zh_cn&edition=full","pubTime":"2026-03-09 22:50","pubTimestamp":1773067834,"startTime":"0","endTime":"0","summary":"截至2026年3月9日收盘,科华生物报收于5.94元,较前一交易日下跌0.5%,最新总市值为30.55亿元。该股当日开盘5.91元,最高5.99元,最低5.88元,成交额达3774.33万元,换手率为1.24%。近日,上海科华生物工程股份有限公司召开第十届董事会第十九次会议,审议通过《关于2026年度向金融机构融资和为子公司提供担保的议案》。公司及子公司拟为资产负债率70%以下的子公司提供总额不超过20,000万元的连带责任担保。该事项无需提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030900035632.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0046","BK0028","002022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618695084","title":"股市必读:科华生物(002022)3月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2618695084","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618695084?lang=zh_cn&edition=full","pubTime":"2026-03-09 02:22","pubTimestamp":1772994134,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘,科华生物报收于5.97元,上涨2.58%,换手率1.48%,成交量7.61万手,成交额4495.97万元。公司生产经营正常,该事项暂未对公司造成重大影响。公司重视市值管理的工作。投资者: 董秘您好,本人是公司股东,依法申请查阅截至 2025 年 1 月 30 日前 200 名股东脱敏名册。《公司法》未规定必须现场查阅,公司强制现场属于不合理限制、变相侵犯股东知情权。公司将在收到完整材料后完成审核并反馈,始终依法依规保障股东合法权益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030900001037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002022","BK0239","BK0188","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614416022","title":"股市必读:科华生物(002022)2月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2614416022","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614416022?lang=zh_cn&edition=full","pubTime":"2026-02-27 01:51","pubTimestamp":1772128270,"startTime":"0","endTime":"0","summary":"截至2026年2月26日收盘,科华生物报收于6.14元,下跌1.29%,换手率1.77%,成交量9.09万手,成交额5600.77万元。董秘最新回复投资者: 您好!建议贵公司可转债可以考虑下修,早点把可转债这边的债务解决了,还有就是亏损的项目早点止损,先把赚钱的项目做好做稳,然后在考虑增加研究新的项目董秘: 尊敬的投资者,您好!当日关注点来自交易信息汇总:2月26日主力资金净流入454.94万元,呈现主动买入态势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700001040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","002022","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777153098708,"stockEarnings":[{"period":"1week","weight":0.0052},{"period":"1month","weight":-0.0017},{"period":"3month","weight":-0.087},{"period":"6month","weight":-0.1231},{"period":"1year","weight":0.0434},{"period":"ytd","weight":-0.0286}],"compareEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":0.0377},{"period":"3month","weight":-0.0136},{"period":"6month","weight":0.0328},{"period":"1year","weight":0.2374},{"period":"ytd","weight":0.028}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海科华生物工程股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"48349人(较上一季度增加7.12%)","perCapita":"10636股","listingDate":"2004-07-21","address":"上海市徐汇区钦州北路1189号","registeredCapital":"51435万元","survey":" 上海科华生物工程股份有限公司的主营业务是体外诊断试剂、仪器的研发、生产和销售。公司的主要产品是体外诊断试剂、仪器。公司及子公司曾获得“国家科技进步二等奖”“国家高新技术企业”“国家知识产权示范企业”“国家发改委生物医学工程高技术产业化示范企业”“中国中小企业创新100强”“上海市著名商标证书”“上海名牌”“上海市科学技术奖”“上海市创新型企业”“陕西省和西安市创新型企业”“陕西省院士工作站”等荣誉,并多次入选上海百强企业多项榜单。","listedPrice":11.12},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科华生物(002022)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科华生物(002022)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科华生物,002022,科华生物股票,科华生物股票老虎,科华生物股票老虎国际,科华生物行情,科华生物股票行情,科华生物股价,科华生物股市,科华生物股票价格,科华生物股票交易,科华生物股票购买,科华生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科华生物(002022)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科华生物(002022)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}